NASDAQ:IONS

Ionis Pharmaceuticals Stock Predictions

Healthcare > Biotechnology

Buy IONS

*Your capital is at risk

$73.82

+0.85 (+1.16%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

IONS Prediction Chart

IONS Predictions History

Latest community submissions for IONS.

Predictor	Target Session	Target Price	Result	Direction	Accuracy
JS Pro	May 16, 2017	$42.78 -4.81%	$44.94	X	95.20%
JS Pro	Nov 29, 2016	$45.11 -2.51%	$46.27	X	97.50%
Abdu Pro @Abdu.1501	Nov 29, 2016	$44.33 -4.19%	$46.27	X	95.80%
larry @larry.1704	Nov 29, 2016	$23.66 -48.87%	$46.27	X	51.10%

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for IONS with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT IONIS PHARMACEUTICALS

Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for familial chylomicronemia syndrome and familial partial lipodystrophy. It also develops medicines for various...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
RUN $12.83	18.86%	May 06
GLBE $31.61	5.35%	May 05
SAP $172.39	10.69%	May 05
W WCLD $27.34	27.18%	Apr 29
ADBE $243.57	7.61%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by